Mucodrenol (Ambroxol Hydrochloride)

Ambroxol Hydrochloride stimulates serous cells in the airway lining to increase the production of thin, watery secretions. This reduces mucus viscosity, enhances mucociliary clearance, and promotes expectoration. It may also exert a mild local anti‑inflammatory effect that supports airway patency.

The appropriate dose of Mucodrenol is determined by a qualified healthcare professional based on the patient’s age, condition severity, and renal function. Patients should follow the prescriber’s instructions and the product label; no universal dosing regimen is provided here.

Safety data for Ambroxol during pregnancy are limited, so use only if the potential benefit justifies the risk. While limited information exists for breastfeeding, the drug may pass into milk; therefore, a healthcare provider should evaluate the risk‑benefit ratio before use.

To order Mucodrenol, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Both ambroxol (Mucodrenol) and acetylcysteine act as mucolytics, but ambroxol primarily enhances serous secretion and has a mild anti‑inflammatory effect, whereas acetylcysteine breaks disulfide bonds in mucus proteins. Clinical choice depends on patient tolerance, specific indication, and physician preference.

Mucodrenol should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and excessive heat. Keep the product out of reach of children and avoid exposure to direct sunlight.

Mucodrenol is taken orally, usually with a glass of water. It can be taken with or without food, but patients should follow the prescriber’s guidance regarding timing relative to meals to minimise gastrointestinal discomfort.

Serious risks include allergic reactions such as urticaria, angioedema, or anaphylaxis, as well as rare severe skin disorders like Stevens‑Johnson syndrome. Hepatic dysfunction and hematologic abnormalities such as eosinophilia have also been reported. Any of these symptoms require immediate medical attention.

Mucodrenol should be avoided in individuals with known hypersensitivity to ambroxol or any excipients in the formulation. Patients with severe renal impairment should consult a physician before use, and those experiencing uncontrolled asthma or bronchospasm should seek medical advice prior to taking the product.